Skip to main content
. 2021 Oct 26;2021:5499963. doi: 10.1155/2021/5499963

Figure 5.

Figure 5

miR-96-5p targets PKN2. Note. (a) ENCORI website showing six candidate target mRNAs of miR-96-5p; (b) the expression of six candidate mRNAs in PTC cells after downregulating miR-96-5p; (c) the protein level of PKN2 in PTC cells after miR-96-5p downregulation was detected by western blot; (d) TargetScan showed the binding region of miR-96-5p on PKN2; (e) the binding relationship between PKN2 and miR-96-5p was validated by luciferase reporter assay; (f) ENCORI website showed the expression of PKN2 in THCA tissues compared to normal tissues; (g) the expression of PKN2 in PTC cell lines compared to normal cells was assessed by qRT-PCR. ∗P < 0.05,  ∗∗P < 0.01, and ∗∗∗P < 0.001.